Jian Qing Zhu (Jianqing Zhu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Endometrial Cancer

Randomized Controlled Trial

Squamous Cell Carcinoma

Top Venues

Journal of gynecologic oncology

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Liujia Qian, Jian Qing Zhu, Zhangzhi Xue, Yan Zhou, Nan Xiang, Hong Xu, Rui Sun, Wangang Gong, Xue Cai, Lu Sun, Weigang Ge, Yufeng Liu, Ying Su, Wangmin Lin, Yuecheng Zhan, Junjian Wang, Shuang Song, Xiao Yi, Maowei Ni, Yi Zhu, Yuejin Hua, Zhiguo Zheng, Tiannan Guo
Proteomic landscape of epithelial ovarian cancer. Nature communications 15 (1) (2024)
Xiaohua Wu, Jihong Liu, Ruifang An, Rutie Yin, Yu Zhang, Huaijun Zhou, Aiqin He, Li Wang, Jieqing Zhang, Ziling Liu, Wei Duan, Jian Qing Zhu, Ge Lou, Guilin Chen, Ying Cheng, Fengxia Xue, Sonja Nick, Haiyan Wang, Donghang Li
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial. Journal of gynecologic oncology (2024)
Yulong Zheng, Jian Qing Zhu, Jianping Xiong, Ou Jiang, Hong Wang, Yanru Xie, Yuefen Zhou, Haiping Jiang
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death-1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105-204). Cancer 130 (12) (2024)
Yulong Zheng, Jian Qing Zhu, Jianping Xiong, Ou Jiang, Hong Wang, Yanru Xie, Yuefen Zhou, Haiping Jiang
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death-1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105-204). Cancer 130 (12) (2024)
Liujia Qian, Jian Qing Zhu, Zhangzhi Xue, Yan Zhou, Nan Xiang, Hong Xu, Rui Sun, Wangang Gong, Xue Cai, Lu Sun, Weigang Ge, Yufeng Liu, Ying Su, Wangmin Lin, Yuecheng Zhan, Junjian Wang, Shuang Song, Xiao Yi, Maowei Ni, Yi Zhu, Yuejin Hua, Zhiguo Zheng, Tiannan Guo
Proteomic landscape of epithelial ovarian cancer. Nature communications 15 (1) (2024)
Liujia Qian, Jian Qing Zhu, Zhangzhi Xue, Yan Zhou, Nan Xiang, Hong Xu, Rui Sun, Wangang Gong, Xue Cai, Lu Sun, Weigang Ge, Yufeng Liu, Ying Su, Wangmin Lin, Yuecheng Zhan, Junjian Wang, Shuang Song, Xiao Yi, Maowei Ni, Yi Zhu, Yuejin Hua, Zhiguo Zheng, Tiannan Guo
Proteomic landscape of epithelial ovarian cancer. Nature communications 15 (1) (2024)
Yulong Zheng, Jian Qing Zhu, Jianping Xiong, Ou Jiang, Hong Wang, Yanru Xie, Yuefen Zhou, Haiping Jiang
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death-1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105-204). Cancer (2024)
Liujia Qian, Jian Qing Zhu, Zhangzhi Xue, Tingting Gong, Nan Xiang, Liang Yue, Xue Cai, Wangang Gong, Junjian Wang, Rui Sun, Wenhao Jiang, Weigang Ge, He Wang, Zhiguo Zheng, Qijun Wu, Yi Zhu, Tiannan Guo
Resistance prediction in high-grade serous ovarian carcinoma with neoadjuvant chemotherapy using data-independent acquisition proteomics and an ovary-specific spectral library. Molecular oncology (2023)
Liujia Qian, Jian Qing Zhu, Zhangzhi Xue, Tingting Gong, Nan Xiang, Liang Yue, Xue Cai, Wangang Gong, Junjian Wang, Rui Sun, Wenhao Jiang, Weigang Ge, He Wang, Zhiguo Zheng, Qijun Wu, Yi Zhu, Tiannan Guo
Resistance prediction in high-grade serous ovarian carcinoma with neoadjuvant chemotherapy using data-independent acquisition proteomics and an ovarian-tissue-specific spectral library. Molecular oncology (2023)
Lingfang Xia, Jing Wang, Chunyan Wang, Qingming Zhang, Jian Qing Zhu, Qunxian Rao, Huijun Cheng, Zheng Liu, Yongmei Yin, Xiaohong Ai, Kurban Gulina, Hong Zheng, Xiaoyong Luo, Baoping Chang, Li Li, Haiyan Liu, Yunxia Li, Ge Lou, Xingtao Long, Yanling Zhu, Zemin Xiao, Jiandong Tong, Ke Wang, Jie Chen, Xia Wang, Lijie Song, Zhixia Wei, Yijing Ye, Jiman Zhu, Xiaohua Wu
Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Feng Cheng, Junjian Wang, Qixun Chen, Jian Qing Zhu
Pulmonary metastasectomy for recurrent metastatic ovarian cancer. The journal of obstetrics and gynaecology research (2023)
Guangyi Jiang, Junjie Hong, Lu Sun, Haibin Wei, Wangang Gong, Shu Wang, Jian Qing Zhu
Glycolysis regulation in tumor-associated macrophages: Its role in tumor development and cancer treatment. International journal of cancer (2023)
Ting Yan Shi, Libing Xiang, Jian Qing Zhu, Ji-Hong Liu, Ping Zhang, Hua Ying Wang, Yanling Feng, Tao Zhu, Yingli Zhang, Aijun Yu, Wei Jiang, Xipeng Wang, Yaping Zhu, Sufang Wu, Yincheng Teng, Jiejie Zhang, Rong Jiang, Wei Zhang, Huixun Jia, Rong Yu Zang
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study. Journal of gynecologic oncology 33 (4) (2022)
Lingfang Xia, Jin Peng, Ge Lou, Mei Pan, Qi Zhou, Wenjing Hu, Huirong Shi, Li Wang, Yunong Gao, Jian Qing Zhu, Yu Zhang, Rong Sun, Xianfeng Zhou, Quanren Wang, Xiaohua Wu
Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study. Journal for immunotherapy of cancer 10 (1) (2022)
Ning Li, Youzhong Zhang, Jing Wang, Jian Qing Zhu, Li Wang, Xiaohua Wu, Desheng Yao, Qiang Wu, Jihong Liu, Junying Tang, Rutie Yin, Ge Lou, Ruifang An, Guonan Zhang, Xiaoping Xia, Qingshui Li, Yaping Zhu, Hong Zheng, Xinfeng Yang, Yuanjing Hu, Xin Zhang, Min Hao, Yi Huang, Zhongqiu Lin, Dong Wang, Xiaoqing Guo, Shuzhong Yao, Xiaoyun Wan, Huaijun Zhou, Liangqing Yao, Xielan Yang, Heng Cui, Yuanguang Meng, Songling Zhang, Jing Qu, Ben Zhang, Jianjun Zou, Ling-Ying Wu
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Qinglei Gao, Jian Qing Zhu, Weidong Zhao, Yi Huang, Ruifang An, Hong Zheng, Pengpeng Qu, Li Wang, Qi Zhou, Danbo Wang, Ge Lou, Jing Wang, Ke Wang, John Low, Beihua Kong, Abdul Malik Rozita, Lim Chun Sen, Rutie Yin, Xing Xie, Jihong Liu, Wei Sun, Jingya Su, Chunyi Zhang, Rongyu Zang, Ding Ma
Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Lingfang Xia, Qi Zhou, Yunong Gao, Wenjing Hu, Ge Lou, Hong Sun, Jian Qing Zhu, Jin Shu, Xianfeng Zhou, Rong Sun, Xiaohua Wu
A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma. Nature communications 13 (1) (2022)
Jun Guan, Yu Xue, Rong Yu Zang, Ji Hong Liu, Jian Qing Zhu, Ying Zheng, Bo Wang, Hua Ying Wang, Xiao-Jun Chen
Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial). Journal of gynecologic oncology 32 (4) (2021)
Ning Li, Hualei Bu, Jihong Liu, Jian Qing Zhu, Qi Zhou, Li Wang, Rutie Yin, Xiaohua Wu, Shuzhong Yao, Kangsheng Gu, Hui Zhang, Hongming Pan, Qiang Wu, Ruifang An, Xinfeng Yang, Xiaoping Wan, Wei Duan, Jianping Xiong, Hongyan Guo, Ge Lou, Jing Wang, Wenjing Hu, Xin Zhang, Yuanguang Meng, Ben Zhang, Yuting Wang, Quanren Wang, Lingying Wu
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Ting Yan Shi, Sheng Yin, Jian Qing Zhu, Ping Zhang, Ji-Hong Liu, Yaping Zhu, Sufang Wu, Xiao-Jun Chen, Xipeng Wang, Yincheng Teng, Tao Zhu, Aijun Yu, Yingli Zhang, Yanling Feng, He Huang, Xiujuan Zhao, Yanli Li, Wei Jiang, Ping Zhang, Jiarui Li, Zhihong Ai, Wei Zhang, Huixun Jia, Yuqin Zhang, Rong Jiang, Jiejie Zhang, Wen Gao, Yuting Luan, Rong Yu Zang
A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study. Journal of gynecologic oncology 31 (3) (2021)
Rong Jiang, Jian Qing Zhu, Jae-Weon Kim, Ji Hong Liu, Kazuyoshi Kato, Hee Seung Kim, Yuqin Zhang, Ping Zhang, Tao Zhu, Daisuke Aoki, Aijun Yu, Xiao-Jun Chen, Xipeng Wang, Ding Zhu, Wei Zhang, Huixun Jia, Ting Yan Shi, Wen Gao, Sheng Yin, Yanling Feng, Libing Xiang, Aikou Okamoto, Rong Yu Zang
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept. Journal of gynecologic oncology 31 (5) (2021)
Xiaohua Wu, Jian Qing Zhu, Jing Wang, Zhong-Qiu Lin, Rutie Yin, Wei Sun, Qi Zhou, Songling Zhang, Danbo Wang, Hong Shi, Yunong Gao, Yi Huang, Guiling Li, Xiuli Wang, Ying Cheng, Ge Lou, Qinglei Gao, Li Wang, Xiuping Du, Mei Pan, Xiyan Mu, Li Li, Miao Li, Song Mu, Beihua Kong
Pamiparib Monotherapy for Patients With Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated With at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Yingli Zhang, Ping Zhang, Lu Chen, Lingqin Zhao, Jian Qing Zhu, Tao Zhu
The Long Non-Coding RNA-14327.1 Promotes Migration and Invasion Potential of Endometrial Carcinoma Cells by Stabilizing the Potassium Channel Kca3.1. OncoTargets and therapy 12 (2019)